Ven Petrochem & Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 23-10-2024
- Paid Up Capital ₹ 6.50 M
as on 23-10-2024
- Company Age 42 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.61 Cr
as on 23-10-2024
- Revenue 28.94%
(FY 2023)
- Profit 25.67%
(FY 2023)
- Ebitda 83.03%
(FY 2023)
- Net Worth 8.22%
(FY 2023)
- Total Assets 1.24%
(FY 2023)
About Ven Petrochem & Pharma (India)
The Corporate was formerly known as Ven-Petro-Chem And Pharmaindia Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.50 M.
The company has closed loans amounting to ₹4.61 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hemal Choksey, Sushil Choksey, and Sunil Patel serve as directors at the Company.
- CIN/LLPIN
U24200MH1982PTC027873
- Company No.
027873
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 1982
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ven Petrochem & Pharma (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Patel  | Managing Director | 27-Feb-1984 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemal Choksey | Director | 18-Jun-1998 | Current |
| Sushil Choksey | Director | 16-Oct-2010 | Current |
Financial Performance of Ven Petrochem & Pharma (India).
Ven Petrochem & Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.94% increase. The company also saw a substantial improvement in profitability, with a 25.67% increase in profit. The company's net worth moved up by a moderate rise of 8.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ven Petrochem & Pharma (India)?
In 2023, Ven Petrochem & Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Development Credit Bank Limited Creation Date: 14 Mar 2011 | ₹4.50 M | Satisfied |
Development Credit Bank Limited Creation Date: 29 Sep 2009 | ₹7.00 M | Satisfied |
Development Credit Bank Limited Creation Date: 15 Dec 2006 | ₹1.50 M | Satisfied |
How Many Employees Work at Ven Petrochem & Pharma (India)?
Unlock and access historical data on people associated with Ven Petrochem & Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ven Petrochem & Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ven Petrochem & Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
